These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

369 related items for PubMed ID: 23683568

  • 1. Prevention of contrast-induced nephropathy by N-acetylcysteine in critically ill patients: different definitions, different results.
    Chousterman BG, Bouadma L, Moutereau S, Loric S, Alvarez-Gonzalez A, Mekontso-Dessap A, Laissy JP, Rahmouni A, Katsahian S, Brochard L, Schortgen F.
    J Crit Care; 2013 Oct; 28(5):701-9. PubMed ID: 23683568
    [Abstract] [Full Text] [Related]

  • 2. N-acetylcysteine in preventing contrast-induced nephropathy assessed by cystatin C.
    Alioglu E, Saygi S, Turk U, Kirilmaz B, Tuzun N, Duman C, Tengiz I, Yildiz S, Ercan E.
    Cardiovasc Ther; 2013 Jun; 31(3):168-73. PubMed ID: 22212518
    [Abstract] [Full Text] [Related]

  • 3. Effect of N-acetylcysteine on cystatin C-based renal function after elective coronary angiography (ENABLE Study): a prospective, randomized trial.
    Kim BJ, Sung KC, Kim BS, Kang JH, Lee KB, Kim H, Lee MH.
    Int J Cardiol; 2010 Feb 04; 138(3):239-45. PubMed ID: 18793808
    [Abstract] [Full Text] [Related]

  • 4. Acetylcysteine in the prevention of contrast-induced nephropathy after coronary angiography.
    Oldemeyer JB, Biddle WP, Wurdeman RL, Mooss AN, Cichowski E, Hilleman DE.
    Am Heart J; 2003 Dec 04; 146(6):E23. PubMed ID: 14661012
    [Abstract] [Full Text] [Related]

  • 5. Improved estimation of glomerular filtration rate by serum cystatin C in preventing contrast induced nephropathy by N-acetylcysteine or zinc--preliminary results.
    Kimmel M, Butscheid M, Brenner S, Kuhlmann U, Klotz U, Alscher DM.
    Nephrol Dial Transplant; 2008 Apr 04; 23(4):1241-5. PubMed ID: 18174269
    [Abstract] [Full Text] [Related]

  • 6. Cystatin C and creatinine as markers for radiocontrast-induced nephropathy in patients treated with N-acetylcysteine.
    Merkle M, Sauter M, Argirov M, Wörnle M.
    Ren Fail; 2010 Jan 04; 32(1):85-90. PubMed ID: 20113272
    [Abstract] [Full Text] [Related]

  • 7. Prospective randomized study of N-acetylcysteine, fenoldopam, and saline for prevention of radiocontrast-induced nephropathy.
    Allaqaband S, Tumuluri R, Malik AM, Gupta A, Volkert P, Shalev Y, Bajwa TK.
    Catheter Cardiovasc Interv; 2002 Nov 04; 57(3):279-83. PubMed ID: 12410497
    [Abstract] [Full Text] [Related]

  • 8. Prophylaxis of contrast-induced nephropathy in patients undergoing coronary angiography.
    MacNeill BD, Harding SA, Bazari H, Patton KK, Colon-Hernadez P, DeJoseph D, Jang IK.
    Catheter Cardiovasc Interv; 2003 Dec 04; 60(4):458-61. PubMed ID: 14624421
    [Abstract] [Full Text] [Related]

  • 9. Prevention of contrast-induced nephropathy with N-acetylcysteine or sodium bicarbonate in patients with ST-segment-myocardial infarction: a prospective, randomized, open-labeled trial.
    Thayssen P, Lassen JF, Jensen SE, Hansen KN, Hansen HS, Christiansen EH, Junker A, Ravkilde J, Thuesen L, Veien KT, Jensen LO.
    Circ Cardiovasc Interv; 2014 Apr 04; 7(2):216-24. PubMed ID: 24714489
    [Abstract] [Full Text] [Related]

  • 10. N-acetylcysteine versus AScorbic acid for preventing contrast-Induced nephropathy in patients with renal insufficiency undergoing coronary angiography NASPI study-a prospective randomized controlled trial.
    Jo SH, Koo BK, Park JS, Kang HJ, Kim YJ, Kim HL, Chae IH, Choi DJ, Sohn DW, Oh BH, Park YB, Choi YS, Kim HS.
    Am Heart J; 2009 Mar 04; 157(3):576-83. PubMed ID: 19249432
    [Abstract] [Full Text] [Related]

  • 11. Prophylaxis of contrast material-induced nephropathy in patients in intensive care: acetylcysteine, theophylline, or both? A randomized study.
    Huber W, Eckel F, Hennig M, Rosenbrock H, Wacker A, Saur D, Sennefelder A, Hennico R, Schenk C, Meining A, Schmelz R, Fritsch R, Weiss W, Hamar P, Heemann U, Schmid RM.
    Radiology; 2006 Jun 04; 239(3):793-804. PubMed ID: 16714461
    [Abstract] [Full Text] [Related]

  • 12. Prediction of contrast-induced nephropathy in patients with serum creatinine levels in the upper normal range by cystatin C: a prospective study in 374 patients.
    Wacker-Gußmann A, Bühren K, Schultheiss C, Braun SL, Page S, Saugel B, Schmid S, Mair S, Schoemig A, Schmid RM, Huber W.
    AJR Am J Roentgenol; 2014 Feb 04; 202(2):452-8. PubMed ID: 24450691
    [Abstract] [Full Text] [Related]

  • 13. Comparison of short-term infusion regimens of N-acetylcysteine plus intravenous fluids, sodium bicarbonate plus intravenous fluids, and intravenous fluids alone for prevention of contrast-induced nephropathy in the emergency department.
    Kama A, Yılmaz S, Yaka E, Dervişoğlu E, Doğan NÖ, Erimşah E, Pekdemir M.
    Acad Emerg Med; 2014 Jun 04; 21(6):615-22. PubMed ID: 25039544
    [Abstract] [Full Text] [Related]

  • 14. Abbreviated dosing of N-acetylcysteine prevents contrast-induced nephropathy after elective and urgent coronary angiography and intervention.
    Ochoa A, Pellizzon G, Addala S, Grines C, Isayenko Y, Boura J, Rempinski D, O'Neill W, Kahn J.
    J Interv Cardiol; 2004 Jun 04; 17(3):159-65. PubMed ID: 15209578
    [Abstract] [Full Text] [Related]

  • 15. A randomized trial of intravenous n-acetylcysteine to prevent contrast induced nephropathy in acute coronary syndromes.
    Jaffery Z, Verma A, White CJ, Grant AG, Collins TJ, Grise MA, Jenkins JS, McMullan PW, Patel RA, Reilly JP, Thornton SN, Ramee SR.
    Catheter Cardiovasc Interv; 2012 May 01; 79(6):921-6. PubMed ID: 21542122
    [Abstract] [Full Text] [Related]

  • 16. Efficacy of ascorbic acid, N-acetylcysteine, or combination of both on top of saline hydration versus saline hydration alone on prevention of contrast-Induced nephropathy: a prospective randomized study.
    Albabtain MA, Almasood A, Alshurafah H, Alamri H, Tamim H.
    J Interv Cardiol; 2013 Feb 01; 26(1):90-6. PubMed ID: 22994682
    [Abstract] [Full Text] [Related]

  • 17. Intravenous N-acetylcysteine plus high-dose hydration versus high-dose hydration and standard hydration for the prevention of contrast-induced nephropathy: CASIS--a multicenter prospective controlled trial.
    Koc F, Ozdemir K, Kaya MG, Dogdu O, Vatankulu MA, Ayhan S, Erkorkmaz U, Sonmez O, Aygul MU, Kalay N, Kayrak M, Karabag T, Alihanoglu Y, Gunebakmaz O.
    Int J Cardiol; 2012 Mar 22; 155(3):418-23. PubMed ID: 21106264
    [Abstract] [Full Text] [Related]

  • 18. Use of NaCl saline hydration and N-Acetyl Cysteine to prevent contrast induced nephropathy in different populations of patients at high and low risk undergoing coronary artery angiography.
    Calabrò P, Bianchi R, Caprile M, Sordelli C, Cappelli Bigazzi M, Palmieri R, Gigantino G, Limongelli G, Capozzi G, Cuomo S, Calabrò R.
    Minerva Cardioangiol; 2010 Feb 22; 58(1):35-40. PubMed ID: 20145594
    [Abstract] [Full Text] [Related]

  • 19. Reno-protective effect of N-acetyl cysteine in patients with impaired renal function undergoing coronary angiography and interventions.
    Ramesh N, Pillai RK, Abraham T, Padmaja NP, Hameed S, Vijayaraghavan G.
    J Assoc Physicians India; 2006 Jun 22; 54():449-52. PubMed ID: 16909692
    [Abstract] [Full Text] [Related]

  • 20. I.v. N-acetylcysteine and emergency CT: use of serum creatinine and cystatin C as markers of radiocontrast nephrotoxicity.
    Poletti PA, Saudan P, Platon A, Mermillod B, Sautter AM, Vermeulen B, Sarasin FP, Becker CD, Martin PY.
    AJR Am J Roentgenol; 2007 Sep 22; 189(3):687-92. PubMed ID: 17715118
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.